MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-11-0001481
Arbro Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹64.16 Cr
▼ 9% YoY
Net loss · FY 2025
₹31.93 Lakh
Net margin -0.5%
EBITDA · FY 2025
₹3.54 Cr
EBITDA margin 5.5%
Authorised capital
₹1.99 Cr
Registered with MCA
Paid-up capital
₹1.78 Cr
Issued & subscribed
Open charges
₹18.9 Cr
Satisfied ₹13.7 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
369
Provident fund records
About Arbro Pharmaceuticals Private Limited
Data last updated:
Arbro Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 June 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL1985PTC021362. Its GSTIN is 07AAACA7893C1ZP (Delhi). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹1.99 Cr and a paid-up capital of ₹1.78 Cr. It was formerly known as Arbro Pharmaceuticals Ltd. It is led by directors including Vijay Kumar Arora (Managing Director) and Sunil Kumar Jaitly (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6/14 Kirti Nagar Industrialarea New Delhi, Delhi, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.16 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net loss of ₹31.93 Lakh (net margin -0.5%) and EBITDA of ₹3.54 Cr (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 9% over five years.
The company has about 369 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Arbro Pharmaceuticals. As per MCA filings, the company has open charges of ₹18.9 Cr and satisfied charges of ₹13.7 Cr on record. Court records list 77 cases involving the company, including 39 filed by the company and 38 filed against it; 10 cases are pending.
Arbro Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0001481). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arbropharma.com.
Company details
CIN U24232DL1985PTC021362
Registration Number 021362
Incorporation Date 28 June 1985
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-11-0001481
CIN history
Arbro Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232DL1985PLC021362. The current CIN is U24232DL1985PTC021362, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232DL1985PTC021362 | Current |
| U24232DL1985PLC021362 | Previous |
Key People
Vijay Kumar Arora Managing Director Sunil Kumar Jaitly Whole-Time Director Saurabh Arora Director Recognitions & Rankings of Arbro Pharmaceuticals
Contact details
Arbro Pharmaceuticals Private Limited's registered office is in Delhi. Its website is arbropharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address6/14 Kirti Nagar Industrialarea New Delhi, Delhi, India
- IndustryPharma, Drug Formulation & Development, Animal Pharmaceuticals & Healthcare
To see the full contact details of Arbro Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Arbro Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Arbro Pharmaceuticals operates one associated brand: Arbro Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceutical formulations , trading of raw materials and Research & Development for pharmaceutical Industry | arbropharma.com |
Business activity
The main business activities of Arbro Pharmaceuticals are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and architecture, engineering activities, technical testing and analysis activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities |
To see the full business activity and turnover split of Arbro Pharmaceuticals Private Limited, buy the company report.
Financials of Arbro Pharmaceuticals Private Limited
FY 2025 filings availableArbro Pharmaceuticals Private Limited reported revenue of ₹64.16 Cr (down 9% YoY) for FY 2025.
Revenue · FY 2025
₹64.16 Cr ▼ 9%
Net loss · FY 2025
₹31.93 Lakh margin -0.5%
EBITDA · FY 2025
₹3.54 Cr margin 5.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 10%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 9%
5 years · compounded
▼ 1%
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.54 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹31.93 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | -0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arbro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Arbro Pharmaceuticals Private Limited
Arbro Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kumar Jaitly | Whole-Time Director | 05 Dec 1998 | 27 Years 10 Months | Current |
| Saurabh Arora | Director | 05 Aug 2005 | 21 Years 2 Months | Current |
| Vijay Kumar Arora | Managing Director | 28 Jun 1985 | 41 Years 3 Months | Current |
Peer comparison
Arbro Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Animal Pharma, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asiatic Drugs and Pharmaceuticals Private Limited | ₹64.49 Cr (FY 2025) | 25.0% | New Delhi, Delhi, India | |||
| Vision Parenteral Private Limited | ₹64.47 Cr (FY 2025) | 8.0% | Gorakhpur, Uttar Pradesh, India | |||
| Astal Laboratories Limited | ₹64.36 Cr (FY 2025) | 172.0% | Noida, Uttar Pradesh, India | |||
| Arbro Pharmaceuticals Private Limitedthis company | ₹64.16 Cr (FY 2025) | -₹31.93 Lakh | -0.5% | -9.0% | 369 | Delhi, India |
| Kilitch Healthcare India Limited | ₹63.63 Cr (FY 2024) | 7.0% | Mumbai, Maharashtra, India | |||
| Sance Laboratories Private Limited | ₹63.45 Cr (FY 2025) | 14.0% | Kottayam, Kerala, India | |||
| Adley Lab Limited | ₹63.38 Cr (FY 2025) | 19.0% | Derabassi, Punjab, India | |||
| Cooper Pharma Limited | ₹63.28 Cr (FY 2024) | -1.0% | Delhi, India |
To see the full peer comparison of Arbro Pharmaceuticals Private Limited, buy the company report.
Auditor
Arbro Pharmaceuticals Private Limited is audited by Satinder Saini & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Satinder Saini & Company | FY 2023 | 008834N |
Shareholding
The shareholding of Arbro Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Arbro Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹18.9 Cr
Satisfied charges
₹13.7 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jul 2025 | 101149781 | Hdfc Bank Limited | ₹7.98 Lakh | Open | |
| 08 Mar 2021 | 100440973 | Hdfc Bank Limited | ₹17.88 Lakh | Open | |
| 28 Aug 2020 | 100388037 | Hdfc Bank Limited | ₹5.21 Lakh | Open | |
| 28 Aug 2018 | 100204454 | Hdfc Bank Limited | ₹4.14 Lakh | Open | |
| 28 Aug 2018 | 100204457 | Hdfc Bank Limited | ₹4.34 Lakh | Open |
To see the full charge records of Arbro Pharmaceuticals Private Limited, buy the company report.
Total charge records: 19 View all charges
Legal cases
Arbro Pharmaceuticals Private Limited has 77 court cases on record: 39 filed by Arbro Pharmaceuticals, 38 filed against it. 10 cases are pending and 67 are disposed.
Total cases
77
Filed by the company
39
Filed against the company
38
Pending
10
Disposed
67
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 58 | 31 | 10 |
| High courts | 18 | 6 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 77)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nashik, Maharashtra | Commercial suit | Filed against the company by Earth Fresh Fruits Pvt.Ltd Through Director Kailash Narayan Waman | Pending |
| District court, West, Delhi | Civil suit | Filed by the company against Coronet Labs Pvt Ltd and 2 others | Disposed |
| High Court of Delhi | Commercial suit | Filed by the company against M/S Maiden Pharmaceuticals Ltd. | Disposed |
| Supreme Court | Court case (2804-Mercantile Laws, Commercial Transactions Including Banking : Trade Marks/Copy Rights/Patents/Design Act) | Filed against the company by Maiden Pharmaceuticals Ltd | Disposed |
| District court, West, Delhi | Civil suit | Filed by the company against Ms Natural Medicaments Ltd | Disposed |
To see the full case history of Arbro Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Arbro Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 56 overdue payments to 18 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 18)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Wang Pharmaceutical & Chemicals | |||
| an individual supplier | |||
| Baddi Foils Private Limited | |||
| Global PT Provider Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Arbro Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Arbro Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Arbro Formulations Private Limited | U24230DL2022PTC395692 |
To see the full group structure of Arbro Pharmaceuticals Private Limited, buy the company report.
Employees & EPFO
Arbro Pharmaceuticals Private Limited has a workforce of 369 employees on its EPFO records as of Aug 31, 2024, across 1 active EPFO establishment.
Employee count
369
Active EPFO establishments
1
Employee growth
-6.58%
GST
Arbro Pharmaceuticals has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACA7893C1ZP | Delhi | Active | 01 Jul 2017 |
| 09AAACA7893C1ZL | Uttar Pradesh | Active | 07 Jan 2018 |
| 06AAACA7893C1ZR | Haryana | Active | 18 Jan 2024 |
To see the full GST registrations and return filing status of Arbro Pharmaceuticals Private Limited, buy the company report.
Recent activity
Arbro Pharmaceuticals Private Limited has 7 board changes on record since 1985: 3 appointments and 4 cessations. The latest: Vinod Kumar Chhabra ceased to be Director on 31 May 2019.
AGM
Arbro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.08 Cr with Charge ID 101149781 was registered on 08 Jul 2025.
Filing
Arbro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Hdfc Bank Limited of Rs. 18.03 Cr registered on 23 May 2017 with Charge ID 100104599 was modified on 09 Jul 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 100440973 was registered on 08 Mar 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.05 Cr with Charge ID 100388037 was registered on 28 Aug 2020.
Ceased
Vinod Kumar Chhabra ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.04 Cr with Charge ID 100204454 was registered on 28 Aug 2018.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.04 Cr with Charge ID 100204457 was registered on 28 Aug 2018.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.05 Cr with Charge ID 100204459 was registered on 28 Aug 2018.
Charges
A charge registered on 29 Apr 2015 via Charge ID 10568928 with Canara Bank was fully satisfied on 07 Jul 2017.
Charges
A charge registered on 24 Mar 2009 via Charge ID 10150277 with Canara Bank was fully satisfied on 07 Jul 2017.
30 earlier events are in the company report.
News
Frequently asked questions
Arbro Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 June 1985 (41+ years old) and is registered under CIN U24232DL1985PTC021362.
Arbro Pharmaceuticals has 3 current directors:
- Vijay Kumar Arora - Managing Director
- Sunil Kumar Jaitly - Whole-Time Director
- Saurabh Arora - Director
The latest financial statements of Arbro Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Arbro Pharmaceuticals is 07AAACA7893C1ZP, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 09AAACA7893C1ZL (Uttar Pradesh), 06AAACA7893C1ZR (Haryana).
The CIN (Corporate Identification Number) of Arbro Pharmaceuticals is U24232DL1985PTC021362. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arbro Pharmaceuticals has 77 court cases on record: 39 filed by the company and 38 filed against it. 10 are pending. Most are in the district courts.
Arbro Pharmaceuticals was incorporated on 28 June 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Arbro Pharmaceuticals by revenue are Asiatic Drugs and Pharmaceuticals Private Limited, Vision Parenteral Private Limited, Astal Laboratories Limited, Kilitch Healthcare India Limited, Sance Laboratories Private Limited and 2 more, all in the Pharma industry (Animal Pharma, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vinod Kumar Chhabra ceased to be Director on 31 May 2019. Promila Arora ceased to be Additional Director on 01 Nov 2016. Ram Avtar Singh ceased to be Director on 01 Aug 2009. Arbro Pharmaceuticals has 7 board changes on record in total.
Yes, Arbro Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-11-0001481).
Arbro Pharmaceuticals has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 56 overdue payments to 18 micro and small suppliers. The latest return was filed on 08 Jun 2019.
Arbro Pharmaceuticals can be reached through the website arbropharma.com. Its registered office is in Delhi, India.